Shonta Bronson
/ Categories: News

IHRC, Inc. authors FDA’s Waste Anesthetic Gases (WAGs) Guide

IHRC, Inc. authors FDA’s Waste Anesthetic Gases (WAGs) Guide

IHRC, Inc. authors FDA’s Waste Anesthetic Gases (WAGs) Guide
The U.S. Food and Drug Administration’s (FDA) Designated Agency Safety and Health Official (DASHO) and Director, Office of Laboratory Safety, released a guide developed by IHRC

Atlanta, GA. - On March 23, 2022, the U.S. Food and Drug Administration (FDA) announced the release of its FDA Waste Anesthetic Gases (WAG) Guide  which the agency’s DASHO and Director of the Office of Laboratory Science (OLS) stated is a “critical resource to support the safety of FDA staff who work with or have the potential for exposure to anesthetic gases”.
The WAG guide, as announced in the OLS Newsletter, “strengthens the understanding of general principles and specific procedures for anesthetic gas safety, as well as techniques that limit exposure, while providing guidance on how to maintain a safe and compliant workplace when working with these gases.”

OLS provides services, policy, and oversight for laboratory science, laboratory security, laboratory design and safety engineering reviews; carries out maintenance and management of primary barrier equipment; provides enterprise-level industrial hygiene services; and supports laboratory quality and safety practices throughout FDA. 

The WAG Guide was developed by Dan Hewett, a Certified Industrial Hygienist and subject matter expert employed by IHRC, Inc. as part of a 5-year contract to provide mission critical support to OLS and enhance the standardization of laboratory practices and policies across the FDA.

IHRC is an international consulting and professional services company focused on providing support in science and health, information management, management consulting, bioinformatics and global health.

About IHRC, Inc.
IHRC is a woman-owned business established and incorporated in Georgia in 2007. IHRC specializes in supporting international public health organizations, federal and state governmental organizations, and private companies engaged in research, diagnosis, prevention, and control of infectious diseases.  
IHRC corporate experience supporting the DHHS includes more than 155 contracts in support of the FDA, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Health Resources and Services Administration (HRSA).

Attachments:

FDA WAG Guide

FDA OLS Newsletter_Message from the Director_DASHO

Previous Article IHRC, Inc. Appoints Ira Plutner Chief Financial Officer
Next Article IHRC, Inc. scientist authors e-Book on biosafety and biosecurity approaches to counter SARS-CoV-2
Print
1341 Rate this article:
3.0

Documents to download

Theme picker

«September 2022»
MonTueWedThuFriSatSun
2930311234
567891011
12131415161718
19202122232425
262728293012
3456789

CMMI Dev Level 3 Appraisal Mark

CMMI Dev Level 3 Appraisal Mark